MétaCan
Menu
← Back to cohort
Record W4241037972 · doi:10.7326/acpjc-2003-139-3-a15

Amlodipine or lisinopril was not better than chlorthalidone in lowering CHD risk in hypertension

2003· article· en· W4241037972 on OpenAlexaffabout
George Heckman

Bibliographic record

VenueACP Journal Club · 2003
Typearticle
Languageen
FieldMedicine
TopicBlood Pressure and Hypertension Studies
Canadian institutionsMcMaster University
Fundersnot available
KeywordsChlorthalidoneLisinoprilMedicineAmlodipineInternal medicineCardiologyAsymptomaticHeart failureStroke (engine)ACE inhibitorDiureticAngiotensin-converting enzymeBlood pressure

Abstract

fetched live from OpenAlex

LetterNovember 1, 2003Amlodipine or lisinopril was not better than chlorthalidone in lowering CHD risk in hypertensionGeorge A. Heckman, MD, FRCPC, Heart and Stroke FellowGeorge A. Heckman, MD, FRCPC, Heart and Stroke FellowGeriatrics and Internal Medicine, McMaster University, Hamilton, Ontario, Canada (G.A.H.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-2003-139-3-A15 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinkedInRedditEmail To the EditorAlthough not mentioned by Dr. Psaty in his commentary (1), concerns have been raised over the heart failure results in ALLHAT (2). Asymptomatic left ventricular (LV) systolic dysfunction is common in older patients, particularly men and patients with cardiovascular risk factors (3, 4). ALLHAT participants were high-risk patients, and many may have had asymptomatic LV dysfunction that could have been unmasked at the start of the study by withdrawal of diuretic therapy. The early difference in heart failure (HF) incidence observed between the lisinopril and chlorthalidone groups, as well as the merging of the HF curves toward the ...References1 Psaty BM.Amlodipine or lisinopril was not better than chlorthalidone in lowering CHD risk in hypertension [Comment]. ACP J Club. 2003;139:7. [PMID: 12841711] Google Scholar2 Williams B. Drug treatment of hypertension: implications of ALLHAT. Heart. 2003;89:589-90. [PMID: 12748205] Google Scholar3 Morgan S, Smith H, Simpson I, et al. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey. BMJ. 1999;318:368-72. [PMID: 9933201] Google Scholar4 Davis RC, Hobbs FD, Kenkre JE, et al. Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study. BMJ. 2002;325:1156. [PMID: 12433768] Google Scholar5 ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-97. [PMID: 12479763] Google Scholar6 Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet. 1999;354:1751-6. [PMID: 10577635] Google Scholar7 Wing LM, Reid CM, Ryan P, et al. A comparison of outcomes with angiotensin-converting–enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003;348:583-92. [PMID: 12584366] Google Scholar8 Gibbs CR, Beevers DG, Lip GY. The management of hypertensive disease in black patients. QJM. 1999;92:187-92. [PMID: 10396605] Google Scholar9 Kuller L, Borhani N, Furberg C, et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol. 1994;139:1164-79. [PMID: 8209875] Google Scholar10 Kitzman DW, Gardin JM, Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 2001;87:413-9. [PMID: 11179524] Google Scholar11 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-12. [PMID: 7823387] Google Scholar Author, Article, and Disclosure InformationAffiliations: Geriatrics and Internal Medicine, McMaster University, Hamilton, Ontario, Canada (G.A.H.) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails November 1, 2003Volume 139, Issue 3Page: A15KeywordsACE inhibitorsCardiovascular diseasesCoronary heart diseaseDiureticsEchocardiographyEjection fractionElderlyEnzymesEpidemiologyHeart failureHospitalizationsHypertensionMedical risk factorsMyocardial infarctionPrevention, policy, and public healthRisk managementSexual identity ePublished: 9 March 2020 Issue Published: November 1, 2003 Copyright & PermissionsCopyright © 2003 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.016
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.008
Threshold uncertainty score0.025

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.016
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0060.004
Insufficient payload (model declined to judge)0.0070.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.046
GPT teacher head0.278
Teacher spread0.231 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2003
Admission routes2
Has abstractyes

Explore more

Same venueACP Journal Club→Same topicBlood Pressure and Hypertension Studies→French-language works237,207→